DMAC Other Income/Expenses (Net)

Diamedica Therapeutics Inc · Other Income/Expenses (Net)

DMAC logo

DMAC Other Income/Expenses (Net)

Latest reported$1.35M
DMAC TTM Other Income/Expenses (Net) (-$6.16K → $1.35M)
High-resolution chart · PNG

DMAC other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Diamedica Therapeutics Inc Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
1,349,000
1,663,000
1,659,000
1,704,000
1,901,000
2,113,000
2,267,000
2,448,000
2,525,000
2,270,000
1,929,000
1,449,000
832,000
574,000
353,000
131,000
28,000
113,000
82,000
150,000
305,000
450,000
434,000
651,000
748,000
785,000
975,000
1,382,681
1,314,681
1,165,681
828,772
282,639
-41,668
-135,729
15,000
90,834
287,873
277,652
307,899
215,841
133,018
97,820
43,051
77,340
127,097
173,030
223,253
212,547
214,736
199,522
-2,541,200
-5,680,105
-8,254,659
-13,368,012
-14,315,906
-11,263,554
-12,212,831
-10,164,111
-9,740,931
-10,004,407
-6,477,362
-3,523,409
-1,183,794
-1,056,370
-1,046,113
-933,584
-677,032
-1,010,080
-1,704,156
-2,356,896
-2,140,192
-2,373,407
-2,093,468
-2,477,943
-2,042,900
-1,614,548
-1,408,602
-398,466
-401,325
-201,717
-5,850
-2,859
-6,164
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.